India reported 1,34,154 new coronavirus infections on Thursday. It takes the total tally of COVID-19 cases to 2,84,41,986 in the country. While the recoveries have crossed 2.63 crores, as per the Union Health Ministry data.
Death count stands at 3,37,989 with 2,887 new fatalities, the data updated at 8 am shows. Moreover, the Serum Institute of India (SII) has asked for indemnity from liability.
“Not just Serum Institute of India (SII), all the vaccine companies should get indemnity protection against liabilities if foreign companies are granted it,” Serum sources said today, adding that rules should be the same for everyone.
The Supreme Court flagging various flaws in the vaccination policy of the Centre slammed it for being arbitrary. It said that the Centre’s policy of giving free vaccination to the 45-plus age group in the first two phases of vaccination and having a paid system for those below is prima facie arbitrary and irrational.
SC questions Centre’s vaccine policy
The apex court also highlighted the pricing issue of vaccines. It has asked the Centre to submit a comparison of the prices of vaccines available in India to their international prices. As in most nations, governments are procuring the vaccines and distributing to the people at no cost.
On the other hand, the government has also said that it will vaccinate the eligible population by December this year.
With the price variation in vaccines, the Congress party has been demanding ‘one nation, one price’. The judges are asking the Centre to produce the entire data on its vaccine purchase history to date.
Furthermore, the Centre will now be clarifying on how the Rs 35,000-crore budget for vaccine procurement is being spent.
The apex court took up this issue suo moto. Countering the Centre’s argument that judiciary must keep off from executive on policies. It reiterates that “Courts cannot be silent spectators when constitutional rights of citizens are infringed by executive policies.”